Studies of antiretroviral therapy in the Multicenter AIDS Cohort Study

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 17, Issue SUPPL. 1, 1998, Pages

  Graham, Neil M H ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

AIDS; HIV; Natural history; Observational database; Seroconversion; Therapy

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AIDS RELATED COMPLEX; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE COURSE; FACTUAL DATABASE; HUMAN; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHASE 4 CLINICAL TRIAL; PROGNOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIBIOTIC PROPHYLAXIS; COHORT STUDIES; DATABASES, FACTUAL; DISEASE PROGRESSION; DRUG RESISTANCE, MICROBIAL; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; ZIDOVUDINE;

EID: 0031619594     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199801001-00004     Document Type: Article

References (10)

1. Kaslow RA, Ostrow DG, Detels R, et al. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-8.
2. Graham NMH, Park LP, Piantadosi S, et al. Prognostic value of combined response markers among human immunodeficiency virus infected persons: possible aid in the decision to change zidovudine monotherapy. Clin Infect Dis 1995;20:352-62.
3. Mellors JW, Rinaldo CR, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272:1167-70.
4. Graham NMH, Astemborski J, Saah AJ, et al. Infectious HIV viral load predicts clinical progression and survival among HIV infected adults. Proc XIth Int Conf AIDS 1996;B.411.
5. Graham NM, Zeger SL, Park LP, et al. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The multicenter cohort study. Lancet 1991;338:265-9.
6. Graham NMH, Hoover DR, Park LP, et al. Survival in zidovudine-experienced patients: comparison of combination therapy with sequential monotherapy and continued zidovudine monotherapy. Ann Intern Med 1996;124:1031-8.
7. Portegies P, de Gans J, Lange JM, et al. Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. BMJ 1989;299:819-21.
8. Enger C, Graham NMH, Peng Y, et al. Survival from early, intermediate, and late stage of HIV infections. JAMA 1996;275:1329-34.
9. Stein DS, Graham NMH, Park LP, et al. The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival in the MACS. Ann Intern Med 1994;121:100-8.
10. Glesby MJ, Hoover DR, Weng S, et al. Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort study. J Infect Dis 1996;173:1477-80.